Bolt Biotherapeutics Inc share price logo

Bolt Biotherapeutics Inc Share Price

NASDAQ: BOLT

Small Cap

$4.28

-0.10

(-2.28%)

as on

Bolt Biotherapeutics Inc Stock Performance

as on March 25, 2026 at 6:40 am IST

  • Day's Low

    Day's High

    $4.21
    $4.48
    downward going graph

    1.64%

    Downside

    4.67%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.91
    $9.66
    downward going graph

    8.64%

    Downside

    125.70%

    Upside

    downward going graph

Bolt Biotherapeutics Inc share price movements today

Previous Close
$4.38
Open
$4.48
Volume
480.0K
Day's Low - High
$4.21 - $4.48
52 Week Low - High
$3.91 - $9.66

Bolt Biotherapeutics Inc Historical Returns

1 Month Return
-10.61 %
3 Month Return
-15.77 %
1 Year Return
-47.86 %
3 Year Return
-83.66 %
5 Year Return
-99.23 %

Bolt Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Bolt Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.1M

EPS (TTM)

-34.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.4

Industry PE ratio

-4.738881355932204

PEG Ratio

0

EBITDA

-33.3M

Revenue (TTM)

7.7M

Profit Margin

0.00%

Return On Equity TTM

-79.75%

Bolt Biotherapeutics Inc Stock Valuation

Track how Bolt Biotherapeutics Inc P/E has moved over time to understand its valuation trends.

Bolt Biotherapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-60.45x)

December 31, 2021

Industry (-4.74x)

March 25, 2026

Today (-0.40x)

March 25, 2026

Highest (-0.47x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.40x

Bolt Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bolt Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Bolt Biotherapeutics Inc image
Bolt Biotherapeutics Inc
BUY$9.1M-99.23%-0.40.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Bolt Biotherapeutics Inc Stock including INR - Dollar returns

The Bolt Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Bolt Biotherapeutics Inc investment value today

Current value as on today

₹60,493

Returns

₹39,507

(-39.51%)

Returns from Bolt Biotherapeutics Inc Stock

₹49,048 (-49.05%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Bolt Biotherapeutics Inc Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Bolt Biotherapeutics Inc. Average target price of $29

Bolt Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Bolt Biotherapeutics Inc.

What analysts predicted

85.24%UPSIDE

Target Price

$29

Current Price

$4.28

Analyzed by

12 Analysts

Target

$29.00

Bolt Biotherapeutics Inc target price $29, a slight upside of 85.24% compared to current price of $4.28. According to 12 analysts rating.

Bolt Biotherapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Bolt Biotherapeutics Inc Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:38% versus previous 30 day period

Bolt Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
2
5
1
1
24
1
1
2
2
Gross Profit
-12
-14
4
1
1
0
1
1
1
1
Operating Income
-18
-19
-17
-22
-16
-15
-12
-9
-7
-5
EBITDA
-17
-19
-16
-18
-16
-15
-11
-8
-6
-5
Interest Expense
-
1
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-17
-10
-21
-15
-15
-11
-8
-7
-6
Income Tax Expense
0
1
0
-
-
-
-
-
-
-
Net Income
-16
-17
-10
-21
-15
-15
-11
-8
-7
-6
Net Profit Margin
-643.08%
-857.01%
-204.99%
-1662.35%
-1330.06%
-66.15%
-903.44%
-474.56%
-329.37%
-265.24%

Bolt Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
1
5
7
7
7
Gross Profit
0
0
-40
-74
-67
-53
7
6
Operating Income
-11
-30
-49
-92
-90
-76
-73
-34
EBITDA
-11
-30
-48
-91
-88
-74
-66
-33
Interest Expense
-
-
-
5
2
-
-
-
Depreciation
0
0
0
1
1
1
1
1
Income Before Tax
-11
-30
-60
-98
-88
-69
-63
-33
Income Tax Expense
0
0
11
5
-2
1
-
-
Net Income
-11
-30
-60
-98
-88
-69
-63
-33
Net Profit Margin
0.00%
-14180.00%
-26289.18%
-7824.68%
-1537.76%
-878.58%
-820.78%
-433.74%

Bolt Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-17
-10
-21
-15
-15
-11
-8
-7
-6
Operating Cash Flow
-14
-16
-16
-13
-14
-13
-9
-9
-7
Investing Cash Flow
15
10
18
17
12
14
10
17
1
Financing Cash Flow
0
-
0
-
0
-
0
-
0
Change in Cash
1
-6
1
3
-2
1
1
8
-6

Bolt Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-30
-60
-98
-88
-69
-63
-33
Operating Cash Flow
-26
-47
-57
-76
-69
-61
-39
Investing Cash Flow
0
-20
-232
57
71
57
44
Financing Cash Flow
48
39
311
0
0
0
0
Change in Cash
21
-28
21
-18
1
-3
4

Global Institutional Holdings in Bolt Biotherapeutics Inc

Funds
Holdings
Sofinnova Ventures
7.17%
Barclays PLC
0%
UBS Group AG
0.01%
UBS Group AG
0%
Pivotal bioVenture Partners Investment Advisor LLC
4.93%
See all

Insights on Bolt Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 1.22M → 2.5M (in $), with an average increase of 20.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -15.93M → -6.63M (in $), with an average increase of 25.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Bolt Biotherapeutics Inc has experienced a drawdown of -83.7%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 73.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 64.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BOLT stock has moved down by -5.5%

About Bolt Biotherapeutics Inc

bolt biotherapeutics is a start-up with compelling technology from dr. engleman’s lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company’s future leaders to help it further develop and bring to patients novel and curative biotherapies.
OrganisationBolt Biotherapeutics Inc
Headquarters900 Chesapeake Drive, Redwood City, CA, United States, 94063
IndustryHealthcare
CEOMr. William P. Quinn
E-voting on sharesClick here to vote

Key Management of Bolt Biotherapeutics Inc

Name

Title

Mr. William P. Quinn

CEO, CFO, President, Secretary & Director

Mr. Grant Yonehiro C.F.A., M.B.A.

COO & Chief Business Officer

Ms. Sarah Nemec

Senior VP of Finance & Principal Accounting Officer

Dr. Michael N. Alonso Ph.D.

Senior Vice President of Research

Mr. Justin Kenkel

Senior Principal Scientist

FAQs

What is Bolt Biotherapeutics Inc share price today?

Bolt Biotherapeutics Inc share price today is $4.28 as on at the close of the market. Bolt Biotherapeutics Inc share today touched a day high of $4.48 and a low of $4.21.

What is the 52 week high and 52 week low for Bolt Biotherapeutics Inc share?

Bolt Biotherapeutics Inc share touched a 52 week high of $9.66 on and a 52 week low of $3.91 on . Bolt Biotherapeutics Inc stock price today i.e. is closed at $4.28,which is 55.69% down from its 52 week high and 9.46% up from its 52 week low.

What is Bolt Biotherapeutics Inc's market capitalisation today?

Bolt Biotherapeutics Inc market capitalisation is $0.00T as on .

How to invest in Bolt Biotherapeutics Inc Stock (BOLT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bolt Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bolt Biotherapeutics Inc Shares that will get you 0.3505 shares as per Bolt Biotherapeutics Inc share price of $4.28 per share as on March 25, 2026 at 1:10 am IST.

What is the minimum amount required to buy Bolt Biotherapeutics Inc Stock (BOLT) from India?

Indian investors can start investing in Bolt Biotherapeutics Inc (BOLT) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Bolt Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Bolt Biotherapeutics Inc share’s latest price of $4.28 as on March 25, 2026 at 1:10 am IST, you will get 2.3364 shares of Bolt Biotherapeutics Inc. Learn more about fractional shares .

What are the returns that Bolt Biotherapeutics Inc has given to Indian investors in the last 5 years?

Bolt Biotherapeutics Inc stock has given -99.23% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?